My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 317

    1.

    Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes.

    Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, Smit AJ.

    Diabetes Care. 2006 Dec;29(12):2654-9.PMID: 17130200 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications.

    Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, Gans RO, Bilo HJ.

    Diabetes Care. 2008 Mar;31(3):517-21. Epub 2007 Nov 26.PMID: 18039805 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Simple non-invasive assessment of advanced glycation endproduct accumulation.

    Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ.

    Diabetologia. 2004 Jul;47(7):1324-30. Epub 2004 Jul 9.PMID: 15243705 [PubMed - indexed for MEDLINE]Related articles

    4.

    Skin autofluorescence in type 2 diabetes: beyond blood glucose.

    Monami M, Lamanna C, Gori F, Bartalucci F, Marchionni N, Mannucci E.

    Diabetes Res Clin Pract. 2008 Jan;79(1):56-60. Epub 2007 Aug 20.PMID: 17707942 [PubMed - indexed for MEDLINE]Related articles

    5.

    Skin autofluorescence is a strong predictor of cardiac mortality in diabetes.

    Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, Smit AJ.

    Diabetes Care. 2007 Jan;30(1):107-12.PMID: 17192342 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.

    Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, Bilo HJ, Smit AJ.

    Diabetologia. 2009 May;52(5):789-97. Epub 2009 Mar 10.PMID: 19274450 [PubMed - indexed for MEDLINE]Related articles

    7.

    Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy.

    Meerwaldt R, Links TP, Graaff R, Hoogenberg K, Lefrandt JD, Baynes JW, Gans RO, Smit AJ.

    Diabetologia. 2005 Aug;48(8):1637-44. Epub 2005 Jul 14.PMID: 16021416 [PubMed - indexed for MEDLINE]Related articles

    8.

    Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?

    Herrera-Pombo JL, Aguilar-Diosdado M, Hawkins F, Campos MM, Moreno A, Garcia-Hernandez A, Castro E, García-Doncel LG, Serraclara A, Sánchez-Malo C, Escobar-Jiménez F.

    Nephron Clin Pract. 2005;101(3):c116-21. Epub 2005 Jul 5.PMID: 16015000 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.

    Galler A, Müller G, Schinzel R, Kratzsch J, Kiess W, Münch G.

    Diabetes Care. 2003 Sep;26(9):2609-15.PMID: 12941727 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease.

    Ueno H, Koyama H, Tanaka S, Fukumoto S, Shinohara K, Shoji T, Emoto M, Tahara H, Kakiya R, Tabata T, Miyata T, Nishizawa Y.

    Metabolism. 2008 Oct;57(10):1452-7.PMID: 18803952 [PubMed - indexed for MEDLINE]Related articles

    11.

    Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy.

    Sato E, Mori F, Igarashi S, Abiko T, Takeda M, Ishiko S, Yoshida A.

    Diabetes Care. 2001 Mar;24(3):479-82.PMID: 11289471 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations.

    Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, Zijlstra F, Smit AJ.

    Diabetes Technol Ther. 2006 Oct;8(5):523-35. Review.PMID: 17037967 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications.

    Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, Epaminonda P, Masserini B, Beck-Peccoz P, Orsi E, Ambrosi B, Arosio M.

    Diabetes Care. 2007 Jan;30(1):83-8.PMID: 17192338 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients.

    Wautier MP, Massin P, Guillausseau PJ, Huijberts M, Levy B, Boulanger E, Laloi-Michelin M, Wautier JL.

    Diabetes Metab. 2003 Feb;29(1):44-52.PMID: 12629447 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A novel advanced glycation index and its association with diabetes and microangiopathy.

    Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V.

    Metabolism. 2005 Aug;54(8):1002-7.PMID: 16092048 [PubMed - indexed for MEDLINE]Related articles

    16.

    Vascular complications of black patients with type 2 diabetes mellitus in Southern Brazil.

    Gerchman F, Zanatta CM, Burttet LM, Picon PX, Lisboa HR, Silveiro SP, Gross JL, Canani LH.

    Braz J Med Biol Res. 2008 Aug;41(8):668-73.PMID: 18797699 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Simple noninvasive measurement of skin autofluorescence.

    Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, Hartog J, Gans R, Smit A.

    Ann N Y Acad Sci. 2005 Jun;1043:290-8.PMID: 16037251 [PubMed - indexed for MEDLINE]Related articles

    18.

    Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.

    Gohda T, Tanimoto M, Moon JY, Gotoh H, Aoki T, Matsumoto M, Shibata T, Ohsawa I, Funabiki K, Tomino Y.

    Diabetes Res Clin Pract. 2008 Aug;81(2):196-201. Epub 2008 Jun 11.PMID: 18550199 [PubMed - indexed for MEDLINE]Related articles

    19.

    Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.

    Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S.

    Diabetes. 1999 Apr;48(4):870-80.PMID: 10102706 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group.

    [No authors listed]

    Diabetologia. 1985 Sep;28 Suppl:615-40.PMID: 4065455 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity